![Marcel van Duin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marcel van Duin
Director Técnico/Científico/I+D en ORGANON & CO. .
Cargos activos de Marcel van Duin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ORGANON & CO. | Director Técnico/Científico/I+D | 01/11/2022 | - |
Historial de carrera de Marcel van Duin
Antiguos cargos conocidos de Marcel van Duin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DNage BV
![]() DNage BV Miscellaneous Commercial ServicesCommercial Services DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH). The Company's main scientific founder Prof J. Hoeijmakers is a world-renowned scientist working on DNA repair and genome stability. His team was the first to establish an explicit connection between DNA damage (lack of repair) and the process of ageing, a scientific breakthrough. DNage has acquired exclusive access to this technology and now focuses on developing therapies to reduce the effects of ageing, leveraging the unique technologies developed by its founders. DNage has matured from an early stage technology company into a drug development company with ongoing clinical trials and several research programs. It has been acquired by Pharming Group NV in October 2006 and is currently involved in a financing round whereby Pharming will reduce its ownership to a non-controlling stake. The team of the company consists of approximately 15 people. DNage has laboratory facilities and offices in Rotterdam and Leiden, The Netherlands. | Director/Miembro de la Junta | - | 21/08/2012 |
Formación de Marcel van Duin.
Erasmus University Rotterdam | Doctorate Degree |
Estadísticas
Internacional
Países Bajos | 3 |
Estados Unidos | 2 |
Operativa
Director/Board Member | 1 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ORGANON & CO. | Health Technology |
Empresas privadas | 1 |
---|---|
DNage BV
![]() DNage BV Miscellaneous Commercial ServicesCommercial Services DNage is a life sciences company founded in 2004 as a spin off from the Department of Genetics of the Erasmus Medical Center Rotterdam. The Company was seed-funded through an equity investment of an international syndicate of venture capitalists including LSP (NL) and Inventages (CH). The Company's main scientific founder Prof J. Hoeijmakers is a world-renowned scientist working on DNA repair and genome stability. His team was the first to establish an explicit connection between DNA damage (lack of repair) and the process of ageing, a scientific breakthrough. DNage has acquired exclusive access to this technology and now focuses on developing therapies to reduce the effects of ageing, leveraging the unique technologies developed by its founders. DNage has matured from an early stage technology company into a drug development company with ongoing clinical trials and several research programs. It has been acquired by Pharming Group NV in October 2006 and is currently involved in a financing round whereby Pharming will reduce its ownership to a non-controlling stake. The team of the company consists of approximately 15 people. DNage has laboratory facilities and offices in Rotterdam and Leiden, The Netherlands. | Commercial Services |
- Bolsa de valores
- Insiders
- Marcel van Duin
- Experiencia